ReviewJMA journal2025
Deep Learning Applications in 12-lead Electrocardiogram and Echocardiogram.
Review in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Optimizing single-lead ECG axis for AI-based detection of myocardial diseases.NPJ cardiovascular health · 2026Article
- Impact of Routine Electrocardiogram Testing in Adult Health Screening on New Outpatient Visit Rates and Cardiovascular Disease Mortality.Circulation reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI), empowered by advances in deep learning technology, has demonstrated its capabilities in the medical field to automate tedious tasks that are otherwise performed by humans or to detect or predict diseases with higher accuracy compared with experts. Given the ability to take complex multidimensional data as input, AI models have primarily been applied to complex medical imaging and time-series data. Another prominent strength of AI applications is its large scalability. The field of cardiovascular medicine uses various noninvasive and accessible metrics that produce a large amount of complex multidimensional data, such as electrocardiograms (ECGs) and echocardiograms. AI models can increase the utility of such modalities. Simple automation of conventional tasks using AI models provides significant opportunities for cost reduction and capacity expansion. The ability to improve disease detection or prediction at scale may provide novel opportunities for disease screening, enabling early intervention in asymptomatic patients. For example, AI-enabled pipelines can accurately identify cardiomyopathies and congenital heart diseases from a single ECG or echocardiogram recording. The detection of these diseases using the conventional approach usually requires complicated diagnostic strategies or expensive tests. Therefore, underdiagnosis is a huge problem. Using AI models to screen these diseases will provide opportunities for reducing missed cases. The utility of AI models in the medical field is not limited to the development of clinically useful models. Recent research has shown the promise of AI models in mechanism research by combining them with genetic and structural analyses. In this review, we provide an update on the current achievements of the innovative AI application for ECG and echocardiogram and provide insights into the future direction of AI in cardiovascular care and research settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.